Related Experiment Videos
Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates
R A Cassidy1, N S Kondo, P S Miller
1Department of Biochemistry and Molecular Biology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Biochemistry
|July 29, 2000
Summary
Chimeric methylphosphonate triplex-forming oligomers (TFOs) bind to HIV DNA, with modifications enhancing stability. These nuclease-resistant TFOs show potential for biological applications due to their DNA-binding ability.
Area of Science:
- Oligonucleotide chemistry
- Molecular biology
- Antiviral drug development
Background:
- HIV-1 integrates its genetic material into host cells, making it a persistent threat.
- Triplex-forming oligomers (TFOs) offer a potential strategy for targeting specific DNA sequences, such as those in the HIV genome.
- Modifications to TFOs, including the use of methylphosphonate backbones and psoralen conjugation, can enhance their stability and DNA-binding properties.
Purpose of the Study:
- To investigate the binding interactions between modified TFOs and a purine tract in the HIV envelope gene (env-DNA).
- To evaluate the impact of specific chemical modifications, such as 5-propynyl-2'-deoxyuridines and methylphosphonate backbones, on TFO-DNA triplex stability.
- To explore the potential utility of these modified TFOs in biological applications.
Main Methods:
- Gel mobility shift assays were employed to assess the binding affinity of TFOs to env-DNA.
- Photo-cross-linking experiments were conducted to identify the sites of interaction and potential adduct formation.
- Chimeric oligodeoxyribo- and oligo-2'-O-methylribo-triplex-forming oligomers (TFOs) with varying backbone compositions (methylphosphonate and phosphodiester) and base modifications were synthesized and tested.
Main Results:
- Pyrimidine chimeric TFOs, particularly those containing 5-propynyl-2'-deoxyuridines, formed stable triplexes with HIV env-DNA, with dissociation constants as low as 400 nM.
- The incorporation of 5-propynyl-uridine enhanced stacking interactions and hydrophobic nature, increasing binding affinity.
- Irradiation of TFO-env-DNA triplexes resulted in photoadducts at the duplex/triplex junction, with modifications influencing adduct formation sites.
Conclusions:
- Chimeric methylphosphonate TFOs demonstrate effective binding to HIV env-DNA, forming stable triplex structures.
- The nuclease resistance of these modified TFOs, combined with their DNA-binding capability, suggests significant potential for use in biological experiments and therapeutic strategies.
- Further research into TFO modifications could lead to the development of novel antiviral agents targeting HIV.